Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer
Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
8 Dec 2017
Two years of extended anastrozole therapy as effective as five
Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
Two years of extended anastrozole therapy as effective as five ( Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
7 Dec 2017
HR–positive advanced breast cancer: Ribociclib improved PFS for pre and...
Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA
HR–positive advanced breast cancer: Ribociclib improved PFS for pre and perimenopausal women ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )
7 Dec 2017
HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive...
Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...
HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive disease free survival ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )
7 Dec 2017
Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast...
Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California...
Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast cancer ( Dr Louis Fehrenbacher - Kaiser Permanente Vallejo Medical Center, California, USA )
7 Dec 2017
Increasing the dose intensity of chemotherapy may lower the risk of breast...
Prof Richard Gray - University of Oxford, Oxford, UK
Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, UK )
7 Dec 2017
Multi gene panels for cancer prevention in Italy
Prof Gennaro Ciliberto - Istituto Nazionale Tumori, Rome, Italy
Multi gene panels for cancer prevention in Italy ( Prof Gennaro Ciliberto - Istituto Nazionale Tumori, Rome, Italy )
6 Dec 2017
A biological perspective for personalising immunotherapies
Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK
A biological perspective for personalising immunotherapies ( Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK )
6 Dec 2017
Precision Panc, a platform for pancreatic cancer
Prof Andrew Biankin - University of Glasgow, Glasgow, UK
Precision Panc, a platform for pancreatic cancer ( Prof Andrew Biankin - University of Glasgow, Glasgow, UK )
6 Dec 2017
Personalised medicine for inherited breast cancer
Dr Fergus Couch - Mayo Clinic, Rochester, Minnesota, United States
Personalised medicine for inherited breast cancer ( Dr Fergus Couch - Mayo Clinic, Rochester, Minnesota, United States )
6 Dec 2017
The reality of pancreatic cancer
Dr Nuria Malats - Spanish National Cancer Research Centre, Madrid, Spain
The reality of pancreatic cancer ( Dr Nuria Malats - Spanish National Cancer Research Centre, Madrid, Spain )
6 Dec 2017
Personalised haematology treatments
Prof Ulrich Jager - Medical University of Vienna, Vienna, Austria
Personalised haematology treatments ( Prof Ulrich Jager - Medical University of Vienna, Vienna, Austria )
6 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation